tm logo
Trademark Search
RETELPRI

View On IC.GC.CA

RETELPRI
REGISTERED

on 28 Feb 2020

Last Applicant/ Owned by

JOHNSON & JOHNSON

One Johnson & Johnson PlazaNew Brunswick, NJ 08933-7001

US

Serial Number

1834262 filed on 25th Apr 2017

Registration Number

TMA1073818 registered on 28th Feb 2020

Registration expiry Date

28th Feb 2030

Correspondent Address

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

RETELPRI

Trademark usage description

human pharmaceuticals for the prevention or treatment of auto-immune diseases, cardiovascular diseases, gastro-intestinal diseases, oncologic diseases Read More

Classification Information

Class [005]
Human pharmaceuticals for the prevention or treatment of auto-immune diseases, cardiovascular diseases, gastro-intestinal diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases; pharmaceutical preparations for the prevention or treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; pharmaceutical preparations for the prevention or treatment of neurological diseases, namely Alzheimer's, Huntington's disease, and cerebral palsy; pharmaceutical preparations for the prevention or treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; anti-viral medications; anti-inflammatory medications; anti-pain medications; and anti-infective medications; human vaccines.

Classification kind code

10

Mark Details

Serial Number

1834262

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 50
on 05th Oct 2018		Allowed
Submitted for opposition 51
on 05th Oct 2018		Allowance Notice Sent
Submitted for opposition 42
on 20th Jun 2018		Advertised
Submitted for opposition 26
on 31st May 2018		Approved
Submitted for opposition 27
on 10th Apr 2018		Approval Notice Sent
Submitted for opposition 22
on 29th Mar 2018		Search Recorded
Submitted for opposition 20
on 29th Mar 2018		Examiner's First Report
Submitted for opposition 31
on 28th Apr 2017		Formalized
Submitted for opposition 30
on 25th Apr 2017		Filed
Submitted for opposition 1
on 25th Apr 2017		Created